Phoenix Holdings Ltd. Vascular Biogenics Ltd. Transaction History

Phoenix Holdings Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.22 - $1.95 $617,811 - $987,485	-506,403 Reduced 49.65%	513,597 $827,000
Q3 2021 Oct 27, 2021	SELL	$1.94 - $2.55 $78,182 - $102,765	-40,300 Reduced 3.8%	1,020,000 $2.09 Million
Q2 2021 Aug 10, 2021	BUY	$1.69 - $2.67 $1.79 Million - $2.83 Million	1,060,300 New	1,060,300 $2.53 Million
Q1 2021 May 10, 2021	SELL	$1.79 - $2.91 $57,050 - $92,747	-31,872 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$1.11 - $1.4 $11,100 - $14,000	10,000 Added 45.72%	31,872 $35,000
Q2 2020 Aug 10, 2020	BUY	$1.12 - $1.63 $24,496 - $35,651	21,872 New	21,872 $27,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.